Additionally, the upregulation of NAG-1 expression by anti-obesity compounds such as resveratrol and quercetin suggests a potential connection between dietary interventions, NAG-1, and the prevention of obesity and CKD. The gene discussed is GDF15; the disease is obesity due to melanocortin 4 receptor deficiency.